SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NewLink Genetics Announces an Investigator Initiated Phase 2 Study of Sipuleucel-T Plus Indoximod in the Treatment of Certain Men With Advanced Prostate Cancer
Your Message